{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:30Z","timestamp":1786985430385,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bmcl.2024.130076","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T15:58:18Z","timestamp":1734364698000},"page":"130076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Synthesis of dolutegravir derivatives modified by 1,2,3-triazole structure and their anti-inflammatory activity in LPS-induced BV2 cells"],"prefix":"10.1016","volume":"117","author":[{"given":"Xixi","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.130076_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.129061","article-title":"Synthesis of 1-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1Hpyrazol-3-yl)-2-morpholinoethane-1,2-dione analogues and their inhibitory activities with reduced cytotoxicity in lipopolysaccharide-induced BV2 cells","volume":"79","author":"Yoon","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.130076_b0010","article-title":"Synthesis and biological evaluation of a ring analogus of the selective CB2 inverse agonist SMM-189","volume":"33","author":"Alghamki","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2024.130076_b0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jff.2018.08.020","article-title":"Sesamin suppresses LPS-induced microglial activation via regulation of TLR4 expression","volume":"49","author":"Udomruk","year":"2018","journal-title":"J Funct Foods"},{"key":"10.1016\/j.bmcl.2024.130076_b0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejmech.2017.12.033","article-title":"Synthesis and biological evaluation of diarylheptanoids as potential antioxidant and anti-inflammatory agents","volume":"144","author":"Maurent","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.130076_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128106","article-title":"Discovery of a novel inhibitor of nitric oxide production with potential therapeutic effect on acute inflammation","volume":"44","author":"Zhu","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.130076_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129408","article-title":"Synthesis of 1-(4-(dimethylamino) phenyl)-3,4-diphenyl-1H-pyrrole-2,5-dione analogues and their anti-inflammatory activities in lipopolysaccharide-induced BV2 cells","volume":"92","author":"Jung","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.130076_b0035","article-title":"HyperiboneJexertsantidepressanteffectsbytargetingADKtoinhibitmicroglial P2X7R\/TLR4-mediated neuroinflammation","author":"Li","year":"2024","journal-title":"J Adv Res"},{"key":"10.1016\/j.bmcl.2024.130076_b0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/bcpt.12414","article-title":"Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease InhibitorsLopinavirand Ritonavir","volume":"5","author":"Fagone","year":"2015","journal-title":"Basic Clin Paharmacol Toxicol"},{"key":"10.1016\/j.bmcl.2024.130076_b0045","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3851\/IMP2039","article-title":"Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by theanti-inflammatorydrug leflunomide in a PPAR-\u03b3-dependent manner","volume":"17","author":"Mencarelli","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.bmcl.2024.130076_b0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.sajb.2019.07.023","article-title":"In vitroinhibition of HIV-1 reverse transcriptase andanti-inflammatoryactivities of some herbal concoctions sold in the Limpopo Province","volume":"126","author":"Matotoka","year":"2019","journal-title":"S Afr J Bot"},{"key":"10.1016\/j.bmcl.2024.130076_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107769","article-title":"Molecular screening of antimalarial, antiviral,anti-inflammatoryand HIV protease inhibitors against spike glycoprotein of coronavirus","volume":"102","author":"Prashantha","year":"2021","journal-title":"J Mol Graph Modell"},{"key":"10.1016\/j.bmcl.2024.130076_b0060","doi-asserted-by":"crossref","first-page":"194)","DOI":"10.1016\/j.ejphar.2013.11.035","article-title":"In vivo administration ofritonavirworsens intestinal damage caused by cyclooxygease inhibitors","volume":"723","author":"Renga","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmcl.2024.130076_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238575","article-title":"A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitortreated subjects living with HIV","volume":"15","author":"Negredo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bmcl.2024.130076_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226924","article-title":"HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells","volume":"15","author":"Auclair","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bmcl.2024.130076_b0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1186\/s12879-024-09565-w","volume":"24","author":"Falasca","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bmcl.2024.130076_b0080","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1080\/14786419.2021.1913590","article-title":"Prenylated coumarins from the fruits of Artocarpus heterophyllus with their potential anti-inflammatory and anti-HIV activities","volume":"36","author":"Tao","year":"2022","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.bmcl.2024.130076_b0085","first-page":"37","article-title":"Bisabolane-type sesquiterpenoids with potential anti-inflammatory and anti-HIV activities from the stems and leaves of Morinda citrifolia","volume":"2023","author":"Zhao","year":"1961","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.bmcl.2024.130076_b0090","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/molecules27010230","article-title":"Recent Advances in Bioactive Flavonoid Hybrids Linked by 1,2,3-Triazole Ring Obtained by Click Chemistry","volume":"27","author":"Pereira","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2024.130076_b0095","article-title":"Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors","volume":"579024","author":"Mao","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2024.130076_b0100","article-title":"1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships","volume":"1","author":"Xu","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.130076_b0105","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/molecules29040837","article-title":"Synthesis and In Vitro Antitumor Activity Evaluation of Gefitinib-1,2,3-Triazole Derivatives","volume":"29","author":"Liu","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2024.130076_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132364","article-title":"Synthesis of novel naphthalimide tethered 1,2,3-triazoles: In vitro biological evaluation and docking study of anti-inflammatory inhibitors","volume":"1254","author":"Begam","year":"2022","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmcl.2024.130076_b0115","doi-asserted-by":"crossref","unstructured":"Hou X, Mao L, Guo Y, Wang L, Peng L, Wang H, Yang J, Li S, Li Y. Synthesis and antitumor activity of dolutegravir derivatives bearing 1,2,3-triazole moieties. BMC Chem, 18, 97.","DOI":"10.1186\/s13065-024-01205-3"},{"key":"10.1016\/j.bmcl.2024.130076_b0120","doi-asserted-by":"crossref","first-page":"9223","DOI":"10.1038\/s41598-024-60000-1","article-title":"Discovery of geftinib\u20131,2,3\u2013triazole derivatives against lung cancer via inducing apoptosis and inhibiting the colony formation","volume":"14","author":"Gao","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2024.130076_b0125","article-title":"Design and synthesis of cabotegravir derivatives bearing 1,2,3-triazole and evaluation of anti-liver cancer activity","volume":"1265289","author":"Xie","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2024.130076_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2015.01.003","article-title":"Synthesis and biological evaluation of phenyl-1H-1,2,3-triazole derivatives as anti-inflammatory agents","volume":"59","author":"Kim","year":"2015","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2024.130076_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111974","article-title":"Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3)","volume":"188","author":"Madasu","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.130076_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130357","article-title":"Synthesis and Molecular Docking of novel 1,3-Thiazole Derived 1,2,3-Triazoles and In vivo Biological Evaluation for their Anti anxiety and Anti inflammatory Activity","volume":"1236","author":"Ankali","year":"2021","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmcl.2024.130076_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128800","article-title":"Synthesis of novel immunomodulatory 1,4-disubstituted bis-1,2,3-triazoles by using click chemistry and their intracellular mechanism of action","volume":"69","author":"Nural","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.130076_b0150","doi-asserted-by":"crossref","first-page":"306","DOI":"10.24820\/ark.5550190.p011.396","article-title":"The synthesis and anti-inflammatory evaluation of 1,2,3-triazole linked isoflavone benzodiazepine hybrids","volume":"7","author":"Mengheres","year":"2020","journal-title":"ARKIVOC"},{"key":"10.1016\/j.bmcl.2024.130076_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108117","article-title":"FPS-ZM1 inhibits LPS-induced microglial inflammation by suppressing JAK\/STAT signaling pathway","volume":"100","author":"Wang","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.bmcl.2024.130076_b0160","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","article-title":"Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases","volume":"53","author":"Tang","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.bmcl.2024.130076_b0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.phrs.2018.12.004","article-title":"Targeting STATs in neuroinflammation: The road less traveled!","volume":"141","author":"Nabavi","year":"2019","journal-title":"Pharmacol Res"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24004785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24004785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T16:24:17Z","timestamp":1737303857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X24004785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":33,"alternative-id":["S0960894X24004785"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.130076","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of dolutegravir derivatives modified by 1,2,3-triazole structure and their anti-inflammatory activity in LPS-induced BV2 cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.130076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130076"}}